Cardinal Health (CAH) Loses Bid to Halt DEA Suspension of Drug Shipment in Florida
Tweet
Share
E-mailGet Alerts CAH Hot Sheet
Join SI Premium – FREE
Shares of Cardinal Health (NYSE: CAH) dipped in mid-day trade Friday afternoon, however, the stock has mostly already erased a chunk of the loss. The move follows headlines from Bloomberg which suggest the company lost a bid to halt the DEA's suspension of a drug shipment in Florida.
The stock is down 0.17 percent to $41.63 at last check.
The stock is down 0.17 percent to $41.63 at last check.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Cardinal Health (CAH) at Outperform
- Nuvectis Pharma (NVCT) files $200M mixed shelf
- Sigma Lithium resumes full operations after signing TAC agreement
Create E-mail Alert Related Categories
Corporate News, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
